The influence of obesity on retention and treatment response of secukinumab in patients with axial spondyloarthritis: Real life data from the Turkbio registry

Karakaş, A.Gülle, S.İnel, T. YüceUslu, S.Avşar, A. KokenKocaer, S. B.Erez, Y.Can, G.Birlik, M.Yazıcı, A.Tufan, A.Dalkıliç, EdizKoca, S. S.Akkoç, N.Akar, S.Sarı, I.Önen, F.Türkbio Registry Grp2024-07-242024-07-242020-06-010003-4967https://doi.org/10.1136/annrheumdis-2020-eular.3961https://ard.bmj.com/content/79/Suppl_1/429.1https://hdl.handle.net/11452/43399Bu çalışma, 03, Haziran 2020 tarihlerinde [ELECTR NETWORK]’da düzenlenen Annual European Congress of Rheumatology (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineRheumatologyThe influence of obesity on retention and treatment response of secukinumab in patients with axial spondyloarthritis: Real life data from the Turkbio registryMeeting Abstract0005559050012344254267910.1136/annrheumdis-2020-eular.39611468-2060